Downregulation of BRCA1 has been associated with a significant increase in the CSC-like populations in breast cancer cells, whereas BRCA1 reconstitution increases cell sensitivity to HDAC inhibitor-induced loss of stemness, thus suggesting that BRCA1 functions as a breast stem cell regulator, while its status may determine tumor response to therapy [283]. Here, BRCA1 is linked to breast carcinoma.